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Techniques for analyzing genome-wide expression proﬁles, such as the microarray technique and next-
generation sequencers, have been developed. While these techniques can provide a lot of information
about gene expression, selection of genes of interest is complicated because of excessive gene expression
data. Thus, many researchers use statistical methods or fold change as screening tools for ﬁnding gene
sets whose expression is altered between groups, which may result in the loss of important information.
In the present study, we aimed to establish a combined method for selecting genes of interest with a
small magnitude of alteration in gene expression by coupling with proteome analysis. We used hy-
percholesterolemic rats to examine the effects of a crude herbal drug on gene expression and proteome
proﬁles. We could not select genes of interest by using standard methods. However, by coupling with
proteome analysis, we found several effects of the crude herbal drug on gene expression. Our results
suggest that this method would be useful in selecting gene sets with expressions that do not show a large
magnitude of alteration.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Recently, methods for analyzing genome-wide expression
proﬁles, such as microarrays and next-generation sequencing,
have been developed. These methods enable us to obtain a large
amount of gene expression data, easily and inexpensively. While
the massive amount of data provides an overview of certain bio-
logical phenomena on the basis of suitable statistical analyses,
there are several limitations. In general, analysis of genome-wide
expression data is carried out by: (1) normalization of the ex-
pression data, (2) selection of genes of interest from the data, and
(3) visualization of expression proﬁles [1]. The most important
step is the selection of genes of interest and determining the
biological signiﬁcance of those selected gene set. In addition, most
researchers select genes with statistically altered expression or
when the magnitude of the fold change between groups is large,
because it is difﬁcult to limit the numbers of genes selected byB.V. This is an open access article u
Division, Research Institute of
hya 836 Suruga-ku, Shizuoka
(K. Yamauchi).using small thresholds [2–4]. However, such methods for the se-
lection of genes often result in the loss of information because
genes that demonstrate large variation in expression within
groups or minor changes in expression between groups are not
selected as genes of interest. Two-dimensional difference gel
electrophoresis (2D-DIGE) is a new technique that compares the
abundance of a large number of proteins, and many researchers
have attempted to use this technique in various areas of research
[5,6]. However, compared to studies utilizing model organisms
that have sufﬁcient genomic information, there are limitations in
analyzing the proteome of non-model organisms whose genomes
have not been sequenced [7], and the throughput of the experi-
ment is lower than that of transcriptome analysis. Additionally,
both proteome and transcriptome analyses have a similar problem
in the selection of candidates, that is, loss of information. Thus,
transcriptome and proteome analyses have both merits and de-
merits. It is necessary to develop new methods for analyzing
transcriptome and proteome data without the loss of information.
In our previous study, we used microarray analysis to de-
termine the effects of a combined extract of Sasa albo-marginata
leaves (kumazasa; Sasa kurinensis Makino), Japanese red pine
leaves (Pinus densiﬂora Sieb. et Zucc), and ginseng roots (Panaxnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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hypercholesterolemia [8]. In that study, we ﬁnally conﬁrmed that
expression of the gene encoding cytochrome P450 7A1 was altered
in response to HCD and HCD with SJG, although we could not
select the gene as a candidate gene of interest by using standard
microarray analysis because of the minor change in gene expres-
sion [8]. This result suggests that it may be difﬁcult to determine
the molecular mechanism underlying the action of crude drugs
using standard methods because changes in gene or protein ex-
pression caused by crude herbal drugs may be smaller than those
caused by most pharmaceutical drugs. However, several plant
polyphenols are known to play a major role in reducing risk of
arteriosclerosis [9–13], suggesting that small molecules from
plants have useful health effects. In this study, we aimed to select
genes of interest whose transcript or protein expression proﬁles
showed small changes by using transcriptome analysis coupled
with proteome analysis and used crude herbal drug-treated rats as
model animals.2. Materials and methods
2.1. Reagents
Immobilized pH gradient strip (pH 3–10), pharmalytes, drystrip
cover ﬂuid, bromophenol blue, agarose, Cy2, Cy3, and Cy5 were
purchased from GE Healthcare (Little Chalfont, UK). Protease in-
hibitor cocktail (Pefabloc SC and Pefabloc SC protector) was pur-
chased from Roche (Mannheim, Germany). Sequence-grade tryp-
sin was obtained from Promega UK (Southampton, Hants, UK). All
other chemicals used in this study were of the highest grade
available and were purchased from GE Healthcare, Dojin Chemical
Japan (Osaka, Japan), Sigma (St. Louis, MO), Wako (Osaka, Japan),
Nacalai Tesque (Kyoto, Japan), or Kanto (Tokyo, Japan). The crude
herbal drug SJG was prepared by Wakanyaku Medical Institute,
Ltd. (Maebashi, Japan). SJG is composed of a water extract of ku-
mazasa leaves and ethanol extracts of Japanese red pine leaves and
ginseng roots in the ratio 8:1:1 [14]. SJG was supplied as a liquid
preparation and diluted using tap water to 50% (v/v). We pre-
viously analyzed the component of SJG and found that SJG con-
tained several compounds like tricin, p-coumaric acid, ginsenoside
[8].
2.2. Animals and treatment
Twenty male Wistar rats (age, 13 weeks) were placed in a room
with controlled lighting (12-h light/dark cycle), temperature
(2371 °C), and humidity (55710%). All rats were provided with
food and tap water or 50% SJG ad libitum throughout the experi-
ment. We divided the rats into four groups (Groups 1, 2, 3, and 4).
After 1 week of habituation, all rats were fed a standard diet (23%510
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Fig. 1. Scheme of the experimental schedule. All rats were acclimatized for a week and fe
52 weeks). After habituation, the rats were divided into four groups. Groups 1 and 3 rece
SJG. In experimental phase II (3 weeks), groups 3 and 4 were fed a high-cholesterol diet.protein, 5% fat, and 55% nitrogen-free extract; MF, Oriental Yeast
Co., Tokyo, Japan) and given water (Groups 1 and 3) or 50% SJG
(Groups 2 and 4) for 12, 30, or 52 weeks (experimental phase I,
Fig. 1). The rats were then provided with food and water as fol-
lows: standard diet and water, Group 1; standard diet and 50% SJG,
Group 2; HCD and water, Group 3; and HCD and 50% SJG, Group
4 for three weeks (experimental phase II, Fig. 1). HCD was the
standard diet supplemented with 0.5% cholesterol and 0.5% cholic
acid. Then, the rats were anesthetized with diethyl ether and sa-
criﬁced. The plasma was collected for measuring the levels of
biochemical parameters, such as glucose, total cholesterol, high-
density lipoprotein (HDL) cholesterol, low-density lipoprotein
(LDL) cholesterol, cholesteryl ester, free cholesterol, triglyceride
(TG), free fatty acid (FFA), phospholipids, and total lipids, and the
livers were collected for RNA extraction. The animal experiments
were approved by the Animal Research Committee of Wakanyaku
Medical Institute, Ltd., and performed in accordance with the
Guidelines for Care and Use of Laboratory Animals at Wakanyaku
Medical Institute, Ltd. and the Guidelines for Proper Conduct of
Animal Experiments from Science Council of Japan.
2.3. Plasma biochemical parameters
Blood samples were obtained from the postcaval vein by using
a vacuum blood collection tube containing heparin. Plasma levels
of glucose, total cholesterol, HDL cholesterol, LDL cholesterol,
cholesteryl ester, free cholesterol, TG, FFA, phospholipids, and total
lipids were determined using the Glucose test Wako (Wako),
L-type Wako cholesterol (Wako), Cholestest N HDL (Sekisui Med-
ical Co., Ltd, Tokyo, Japan), Cholestest LDL (Sekisui), L-type Wako
cholesterol (Wako) and L-type Wako free cholesterol (Wako),
L-type Wako free cholesterol (Wako), L-type Wako TG (Wako),
NEFA-SS Eiken (Eiken Chemical Co., Ltd, Tokyo, Japan), L-type
Wako phospholipids (Wako), and Total lipids reagent Kokusai
(Sysmex, Kobe, Japan), respectively.
2.4. RNA isolation and microarray analysis
Isolation of total RNA from the liver and microarray analyses
were performed according to the methods described in our pre-
vious study [8]. Total RNA was extracted from frozen rat livers by
using the High Pure RNA Isolation Kit (Roche) and subjected to
oligonucleotide array analysis (Agilent Microarray Design ID
028279; Agilent, Santa Clara, CA, USA) by using a single-color la-
beling system (Low Input Quick Amp Labeling Kit for One Color;
Agilent). We performed t tests or Benjamini and Hochberg's
method to compare signals between two groups, and a Venn
diagram was created to extract genes whose expression was al-
tered by the intake of HCD, and the expression was further mod-
iﬁed by SJG. All analyses for microarray data were performed using
linear models for microarray data (limma) package [15] or Subio(week) 653
Sacrifice, plasma collection, 
RNA extraction from liver 
Experimental Phase II 
Water or SJG 
Standard diet or High cholesterol diet 
3 
1 
16 
34 
d a standard diet throughout habituation and the experimental phase I (12, 30, and
ived water throughout the experimental phase, while groups 2 and 4 received 50%
Finally, all the rats were sacriﬁced, and plasma and liver were collected for analysis.
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genes whose expressions were altered by SJG (Supplementary Fig.
S1A and B). To select the genes whose expression patterns were
similar to certain gene, ﬁrst of all, we obtained average vector of
the gene. After that we calculated the Peason's correlation be-
tween the gene and remaining all genes on one-on-one level. Fi-
nally, we selected the genes which had high correlation (r40.85).
2.5. 2D-DIGE
2D-DIGE was performed as described by Yamanaka et al. [16].
In brief, liver samples were homogenized in 10 volumes of lysis
buffer that contained 4% (w/v) CHAPS, 2 M thiourea, 8 M urea,
10 mM Tris–HCl (pH 8.8), 4 mM Pefabloc SC, 20 mM Pefabloc SC
protector on ice by using a Potter type homogenizer, followed by
sonication. After centrifugation was performed at 20,800 g for
20 min at 10 °C, the supernatant was collected as the protein
sample. Protein concentration of each sample was determined
using the dye-binding method [17] with transferrin as the stan-
dard, and protein samples (50 μg) were labeled with 200 pmol of
N-hydroxy succinimidyl ester-derivatives of cyanine dyes Cy3 or
Cy5. A mixture of all protein samples was labeled with Cy2 and
used as the standard on all gels. Labeled samples and the standard
were run on the same gel, and 2-dimensional electrophoresis was
performed. We used wide-range immobilized pH gradient strips
(pH 3–10, 24 cm). Separation in the ﬁrst dimension was performed
using Multiphor II (GE Healthcare) at 54 kV h and 20 °C under
darkness. Then, we used 12% T, 7.5% C gels (24 cm20 cm) for
separation in the second dimension with Ettan DALT twelve (GE
Healthcare) at 2 W/gel and 20 °C. The gels were scanned directly
with the 2920 2D-Master Imager (GE Healthcare), and the scanned
images were analyzed using the Decyder (Version 4.00) software
(GE Healthcare) to quantify the amount of proteins. We performed
t tests to compare signals between two groups, and a Venn dia-
gram was created to select the proteins whose levels were altered
by HCD intake, and the levels were further altered by SJG (Sup-
plementary Fig. S1C). Then, gel electrophoresis for mass spectro-
metry (MS) was performed using 600 μg of a mixture of all liver
protein samples by using the same above mentioned procedure.
After ﬁxation and staining of the gels, selected proteins were ob-
tained from the gels by using an automated spot picker (GE
Healthcare), and the gels were washed with 50 mM ammonium
bicarbonate and acetonitrile. Then, the gels were incubated with
12.5 ng/μl trypsin (Promega) at 30 °C for 15 h. The peptides were
eluted from the gels with 50 mM ammonium bicarbonate, fol-
lowed by 10% (v/v) formic acid and acetonitrile. The solvent was
changed to 0.1% (v/v) formic acid. The peptides were concentrated
and desalted using the C18 PepMap column (300-μm id/5 mm in
length; LC Packings, San Francisco, CA), followed by MS/MS se-
quencing with an automated MS-to-MS/MS switching protocol.
Spectrum processing and peak annotations were performed, and
processed spectra were searched using the Mascot database (Ma-
trix Science, London, UK).
2.6. Statistical analysis
The microarray and proteome data are presented as means of
log-normalized expression7SEM. Differences between the groups
were analyzed using Kruskal-Wallis analysis with Scheffe's mul-
tiple-comparison post-tests for non-normally distributed values or
one-way analysis of variance (ANOVA) with Bonferroni's multiple-
comparison post-tests for normally distributed values to evaluate
the signiﬁcance of the differences. A value of Po0.05 was con-
sidered statistically signiﬁcant.3. Results
3.1. Effects of SJG on plasma and liver parameters
HCD rats were untreated or treated with SJG for 12 (short-
term), 30 (medium-term), or 52 (long-term) weeks. Total choles-
terol levels were highest in rats from the long-term experiment
and lowest in rats from the short-term experiment, suggesting
that cholesterol levels become elevated with age. HCD-induced
hypercholesterolemia was improved by treatment with SJG in rats
from the medium-term experiment (Table 1). Similar tendencies
were observed for the short- and long-term experiments. Thus, we
examined the genome-wide expression proﬁles in all three ex-
periments. Treatment with SJG did not affect HCD-induced ele-
vation of LDL cholesterol and free cholesterol levels. We also found
that treatment with SJG did not affect glucose, TG, FFA, phospho-
lipids, or total lipid levels. In addition, HCD induced fatty liver, and
treatment with SJG did not ameliorate this effect (Table 1).
3.2. Effects of SJG on the genome-wide expression proﬁle
We performed microarray analyses to identify gene sets whose
expression was altered in the presence of of HCD, and then further
affected by the presence of SJG. We identiﬁed only one gene in the
long-term experiment by using Limma software (Supplementary
Fig. S1A), and 44, 29, and 163 genes in the short-, medium-, and
long-term experiments, respectively (Supplementary Fig. S1B), by
using the Subio software. We did not identify any genes whose
expression patterns were the identical or somewhat similar in the
three experiments (Fig. 2).
3.3. Effects of SJG on the protein expression proﬁle and comparison
with the microarray results
We examined the protein expression proﬁles in the livers of rats
from the long-term experiment because this group had the most af-
fected genes in the standard microarray analysis (163 genes; Supple-
mentary Fig. S1B). Then, we selected the proteins whose levels were
altered by the intake of HCD, and were further affected by treatment
with SJG, using a similar procedure for standard microarray analysis
(Supplementary Fig. S1C), and identiﬁed paraoxonase 3 (PON3) and
protein disulﬁde isomerase (PDIA1) as candidates (Fig. 3A and B, re-
spectively). We found that expression of PON3 and PDIA1 transcripts
(Fig. 3C and D, respectively) were comparable (Fig. 3A versus 3C; 3B
versus 3D) to the protein expression. While PON3 protein levels and
transcript levels of PON3 and PDIA1 in each experimental group
showed normally distributed values, PDIA1 protein levels had non-
normal distribution. The mean value and SEM of processed PON3
protein levels were 0.118 and 0.025 (MFþWater), 0.024 and 0.037
(MFþSJG), 0.106 and 0.067 (HCDþWater), and 0.019 and 0.032
(HCDþSJG), respectively. The mean value and SEM of processed PON3
transcript levels were 0.014 and 0.026 (MFþWater), 0.028 and 0.026
(MFþSJG), 0.056 and 0.036 (HCDþWater), and 0.014 and 0.028
(HCDþSJG), respectively. The mean value and SEM of processed PDIA1
transcript levels were 0.029 and 0.033 (MFþWater), 0.041 and 0.019
(MFþSJG), 0.056 and 0.021 (HCDþWater), and 0.015 and 0.015
(HCDþSJG), respectively. The median value, 25th percentile, and 75th
percentile of processed PDIA1 protein levels were 0.084, 0.059, and
0.112 (MFþWater), 0.004,0.029, and 0.025 (MFþSJG), 0.075,
0.146, and 0.056 (HCDþWater), and 0.045, 0.033, and 0.053
(HCDþSJG), respectively. We analyzed the PON3 protein levels and
transcript levels of both genes using one-way ANOVA with Bonferro-
ni's post-hoc test, and analyzed PDIA1 protein levels using Kruskal-
Wallis test with Scheffe's post-hoc test. We found that protein levels of
PON3 and PDIA1 were altered signiﬁcantly between the groups while
we did not observe any signiﬁcant differences in transcript levels of
Table 1
Several parameters in plasma and liver.
Sample Parameters Period Experimental conditions
MFþwater MFþSJG HCDþwater HCDþSJG
Blood Glucose (mg/dl) 12week 110.474.8 a 107.473.4 a 105.074.4 a 111.877.4 a
30week 122.879.8 a 125.676.8 a 115.075.2 a 126.474.2 a
52week 111.674.2 a 110.877.2 a 111.076.4 a 101.871.2 a
Total cholesterol (mg/dl) 12week 66.070.8 a 63.873.0 a 93.875.1 b 91.275.2 b
30week 73.673.8 a 79.876.3 a 112.674.8 b 91.074.3 a
52week 108.275.4 a 87.678.6 a 124.6719.5 a 113.273.9 a
HDL cholesterol (mg/dl) 12week 17.670.4 a 17.870.4 a 22.070.5 b 19.270.6 a
30week 17.670.7 a 18.070.7 a 22.471.1 b 18.070.8 a
52week 22.670.8 a 20.871.5 a 22.873.5 a 23.071.2 a
LDL cholesterol (mg/dl) 12week 5.870.2 a 6.070.4 a 18.471.7 b 21.472.0 b
30week 6.070.3 a 6.870.7 a 20.871.4 b 17.671.1 b
52week 12.871.0 a 10.070.9 a 29.275.8 b 25.871 b
Cholesteryl ester (mg/dl) 12week 56.270.6 a 54.472.3 a 79.874.3 b 78.474.5 b
30week 54.672.9 a 59.474.5 ac 89.473.8 b 71.273.5 c
52week 89.074.7 a 74.276.8 a 104.0716.5 a 95.873.4 a
Free cholesterol (mg/dl) 12week 9.870.4 a 9.470.7 a 14.070.8 b 12.870.7 b
30week 19.070.9 a 20.471.9 a 23.271.0 a 19.870.9 a
52week 19.271.2 a 13.471.8 a 20.673.0 a 17.470.5 a
TG (mg/dl) 12week 128.6718.4 a 109.8715.4 a 86.276.8 a 88.477.3 a
30week 161.4729.4 a 148.4718.6 a 121.879.2 a 103.8713.2 a
52week 290.2738.8 a 218.2720.5 ac 156.8722.2 bc 176.279.2 bc
Free fatty acid (μEq/l) 12week 839.6759.7 a 838.6769.4 a 738.4755.7 a 809.0779.1 a
30week 787.2742.4 a 845.0774.7 a 911.8765.4 a 736.0745.8 a
52week 964.6754.7 a 981.0746.7 a 869.2789.0 a 928.6752.3 a
Phospholipids (mg/dl) 12week 113.272.8 a 109.474.3 a 113.273.5 a 106.074.0 a
30week 119.874.8 a 125.278.1 a 125.675.0 a 111.675.2 a
52week 166.477.6 a 140.6710.8 a 131.4714.9 a 125.875.1 a
Total lipids (mg/dl) 12week 308.4717.2 a 287.0718.8 a 337.8715.7 a 344.4722.5 a
30week 391.0729.5 a 392.2732.9 a 451.6714.5 a 383.0717.7 a
52week 563.4737.1 a 484.0735.4 a 501.4758.9 a 499.6715.6 a
Liver Total cholesterol (mg/100 g) 12week 506.879.8 a 488.078.8 a 3582.57271.0 b 4119.37298.5 b
30week 504.3715.0 a 512.876.9 a 4302.07190.9 b 3988.77203.1 b
52week 760.2720.6 a 739.6720.1 a 5112.57373.1 b 4303.47154.5 b
Each value is the mean7SEM of four individuals. Different letters (a, b, and c) denote a statistically signiﬁcant difference in means (Po0.05; one-way ANOVA with
Bonferroni's multiple-comparison post-tests for multiple comparisons).
42 0 
0 
28 
2 1 
160 
12 weeks 30 weeks
52 weeks
Fig. 2. Results of genome-wide expression analysis of the liver of diet-induced
hypercholesterolemic rats. Venn diagrams showing the number of genes altered by
cholesterol or a combination of cholesterol and SJG in the short- (12 weeks),
medium- (30 weeks), and long-term (52 weeks) experiments. The total number of
genes whose expressions were altered by HCD intake and further modiﬁed by SJG
was 44, 29, and 163 in the short-, medium-, and long-term experiments, respec-
tively. No genes showed similar expression patterns in all three experiments.
A. Ishihara et al. / Biochemistry and Biophysics Reports 7 (2016) 63–6966either gene. SJG was potent enough to recover HCD-induced reduction
of PON3 and PDIA1 levels.
We searched for data about PDIA1 in the Kyoto Encyclopedia of
Genes and Genomes (KEGG) database. This gene is associated with
“protein processing in endoplasmic reticulum” (accession number,
rno04141). We collected expression data for 30,451 transcripts by
using microarray. Of the 30,451 genes, 184 were associated with the
rno04141 pathway, and 3998 had expression patterns that were si-
milar to that of PDIA1 (Pearson's correlation, r40.85, Table 2). Of the
3998 genes, 37 genes (Supplementary Table S1) were associated with
the rno04141 pathway (Table 2). By analyzing these data with the
Fisher's exact test, we found that the genes with expression patterns
similar to that of PDIA1 were signiﬁcantly enriched in the rno04141
pathway (Table 2, Po0.01). These results suggest that intake of HCD
reduces the expression of genes in this pathway and that SJG may play
a role in the recovery of that expression.
PON3 is a member of the arylesterase/paraoxonase family, and it
acts as an anti-atherosclerotic agent by binding to HDL [18]. We could
not ﬁnd atherosclerosis-related pathways in the KEGG database. Thus,
we examined the expression proﬁles of genes related to the formation
of atherosclerotic lesions, such as PON1, PON2, PON3, matrix metallo-
proteinase 9 (MMP9), scavenger receptor AI (SR-AI), CD36, lectin-type
oxidized LDL receptor 1 (LOX1), and endothelial nitric oxide synthase
(eNOS), and found that HCD-induced changes in the expression of
these genes tended to improve with SJG intake (Fig. 4). However, the
expression of several other genes with possible roles in the formation
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Fig. 3. Results of proteome and transcriptome analyses of the liver of diet-induced hypercholesterolemic rats. Two-dimensional gel electrophoresis of rat liver proteins was
performed using immobilized pH 3–10 gradient strips, followed by SDS-PAGE (12% T, 7.5% C). Panels A and B represent quantiﬁed data for proteome analysis of PON3 and
PDIA1, respectively. Panels C and D represent quantiﬁed data for transcriptome analysis of PON3 and PDIA1, respectively. The vertical axis represents the standardized
quantity of the target protein or transcript for each sample (n¼5 for proteome analysis and n¼4 for transcriptome analysis). The open circle represents the standardized
quantity of each sample. The line represents the average value for each treatment group. Different letters denote a statistically signiﬁcant difference in means (Po0.05;
Kruskal-Wallis analysis with Scheffe's multiple-comparison post-tests or one-way ANOVA with Bonferroni's multiple comparison post-test for multiple comparison).
A. Ishihara et al. / Biochemistry and Biophysics Reports 7 (2016) 63–69 67of atherosclerotic lesions, such as intercellular adhesion molecule 1
(ICAM1), vascular cell adhesion molecule 1 (VCAM1), C-C chemokine
receptor type 2, macrophage colony-stimulating factor (MCSF),
monocyte chemotactic protein-1, interleukin-6, and tumor necrosis
factor alpha (TNF-α), were not affected (data not shown).4. Discussion
In the present study, we aimed to establish a combined method
for analyzing data from transcriptome experiments coupled withTable 2
Pathway enrichment analysis using Fisher’s exact test.
Number of genes associated wit
pathway rno04141
Number of genes whose expression was similar to
PDIA1
37
Number of genes whose expression was not similar
to PDIA1
147
Total 184
Genes whose expression was similar to that of PDIA1 were selected according to Peason
(protein processing in endoplasmic reticulum). Po0.01 (Fisher's exact test, two-tailed).proteome analyses, which enabled us to identify genes of interest
that could not be selected using standard methods. Crude herbal
drugs are usually prepared from several plants and are thought to
have mild effects when compared to the effects of pharmaceutical
agents. Thus, changes caused by treating organisms with herbal
crude drugs may not be large enough, making it difﬁcult to obtain
useful information from genome-wide experiments using stan-
dard methods. First, we examined several serum parameters and
found that total cholesterol and HDL cholesterol levels were ele-
vated by HCD intake and that the HCD-induced increases of total
cholesterol or HDL cholesterol were recovered by SJG in theh the KEGG Number of genes not associated with the KEGG
pathway rno04141
Total
3961 3998
26,306 26,453
30,267 30,451
's correlation (40.85), and were enriched signiﬁcantly in KEGG pathway rno04141
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Fig. 4. Expression proﬁles of the genes related to the formation of atherosclerotic lesions. Data were extracted from the microarray results. The panels represent the
expression proﬁles of PON1 (A), PON2 (B), PON3 (C), MMP9 (D), SR-AI (E), CD36 (F), LOX1 (G), and eNOS (H). The vertical axis represents the ratio of the quantity of the target
gene transcript for each sample to that of group 1 samples as a magnitude of induction (fold change) after global normalization (n¼4). Each value is mean7SEM. Different
letters denote a statistically signiﬁcant difference in means (Po0.05; one-way ANOVA with Bonferroni's multiple-comparison post-tests for multiple comparisons).
A. Ishihara et al. / Biochemistry and Biophysics Reports 7 (2016) 63–6968medium-tern experiment or short- and medium-term experi-
ments, respectively. Although the effect of SJG was not consistent
among the short-, medium-, and long-term experiments, it is
possible that SJG has beneﬁcial effects on cholesterol homeostasis
in liver.
Next, we attempted to extract gene sets from genome-wide ex-
pression proﬁles using standard methods. However, we could not ﬁnd
gene(s) with expression commonly altered in short-, medium-, and
long-term experiments (Fig. 2). Additionally, PON3 and PDIA1, which
were not selected by standard methods, were selected from proteomeanalysis. These results suggested that, at least in this study, it is difﬁ-
cult to obtain useful candidates using standardmethods. Therefore, we
performed proteome analysis of samples from the long-term experi-
ment and found that PON3 and PDIA1 levels were reduced by HCD
intake and that SJG recovered the levels (Fig. 3A and B). Gene ex-
pression patterns of PON3 and PDIA1 in the long-term experiment
were comparable to the protein expression patterns (Fig. 3C and D).
Based on these results, it is evident that we were unable to identify
PON3 and PDIA1 as genes of interest using standard methods. How-
ever, we could identify PON3 and PDIA1 as candidate proteins from
A. Ishihara et al. / Biochemistry and Biophysics Reports 7 (2016) 63–69 69the proteome analyses and found a correlation between the transcript
and protein levels of both these genes. There might be several cases in
which expression levels are different between the protein and the
transcript because the protein functions are altered due to post-
translational modiﬁcations like acetylation, methylation, or phos-
phorylation. Although, in such cases, it will be more difﬁcult to identify
the genes of interest from transcriptomic data, the combined analytical
method is considered a powerful tool because it provides a large
amount of data.
We demonstrated that genes with expression patterns similar
to that of PDIA1 were signiﬁcantly enriched in the “protein pro-
cessing in endoplasmic reticulum” pathway, suggesting that pro-
tein processing was decreased by HCD intake and that SJG had the
ability to recover the HCD-induced decrease, even if the magni-
tude of the change was small (Table 2).
PON1 and PON3 had similar expression patterns (Fig. 4). PON1 and
PON3 are synthesized mainly in the liver and bind to HDL [18]. PON1-
HDL and PON3-HDL have antioxidant activity and prevent the oxida-
tion of LDL during oxidative stress [19,20]. Oxidized LDL plays a role in
the occurrence or progression of atherosclerosis by acting as a signal
molecule. Oxidative stress increases the migration of monocytes and
upregulates the expression of adhesion molecules, including ICAM1
and VCAM1 [21]. After binding to adhesion molecules, monocytes are
stimulated byMCSF to move into the subendothelial region [22]. Then,
the monocytes are further stimulated by oxidized LDL in the sub-
endothelial region, and they differentiate into macrophages [22].
Scavenger receptors, such as SR-AI, CD36, and LOX1, play an important
role in these steps [22]. In addition, inﬂammation, migration of
smooth muscle cells, and interactions with the extracellular matrix
increase cytokine levels, which causes the macrophages to form foam
cells [23–28]. MMP9 induces the rupture of atherosclerotic lesions and
causes ischemic heart disease [22,29]. Thus, the effects of SJG on HCD-
induced reduction of PON1 and PON3may lead to the improvement of
atherosclerosis. The expression of genes related to the formation of
atherosclerosis, including scavenger receptors, adhesion molecules,
and MMPs, was improved after treatment with SJG.
In conclusion, we established a combined method for the
analysis of transcriptome experiments by coupling with themwith
proteome experiments, and we identiﬁed genes of interest that
were not identiﬁed using standard methods. These methods will
be useful in identifying gene sets that do not show large changes
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